Covid-19: Gilead withdraws orphan drug designation from potential treatment after criticism British Medical Journal Media Article
In rare move, Gilead gives up ‘orphan’ status for experimental coronavirus drug BioPharma Drive Media Article
Learn more about how you can help build a more equitable system for all Notice: JavaScript is required for this content.